Cardiovascular Risk Clinical Trials in London
4 recruitingLondon, United Kingdom
Showing 1–4 of 4 trials
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
HypertensionCardiovascular RiskBlood Pressure Check (Hypertension Screening)
Aktiia SA15,000 enrolled2 locationsNCT06670677
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
Cardiovascular DiseasesCardiovascular Risk Factors
University of Oxford250,000 enrolled37 locationsNCT05169333